Utah Medical Products (UTMD) Income from Continuing Operations (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Income from Continuing Operations of 2604000.0 for Q1 2026, down 14.37% year-over-year from 3041000.0 in Q1 2025, and up 33.4% quarter-over-quarter from 1952000.0 in Q4 2025.
Utah Medical Products (UTMD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Utah Medical Products' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 2604000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 14.37% year-over-year to 2604000.0; the TTM figure through Mar 2026 stood at 10235000.0 (down 26.96% YoY), while the FY2025 annual figure was 10672000.0, down 23.81% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 2604000.0, up from 1952000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 8251000.0 in Q4 2022, with the low at 3525000.0 in Q4 2023.
- The 5-year median for Income from Continuing Operations is 3534000.0 (2022), against an average of 3180000.0.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations jumped 204.81% in 2022, then sank 142.72% in 2023.
- Utah Medical Products' Income from Continuing Operations stood at 8251000.0 in 2022, then plunged by 142.72% to 3525000.0 in 2023, then jumped by 123.26% to 820000.0 in 2024, then soared by 138.05% to 1952000.0 in 2025, then surged by 33.4% to 2604000.0 in 2026.
- Business Quant data shows UTMD's Income from Continuing Operations at 2604000.0 in Q1 2026, 1952000.0 in Q4 2025, and 2631000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn | 2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.69 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 3.05 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 820,000.00 |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 3.45 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | -3.53 Mn |
| Sep 30, 2023 | 3.94 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 8.25 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Dec 31, 2021 | -7.87 Mn |
| Sep 30, 2021 | 4.21 Mn |